As of January 22, 2025, I-Mab Biopharma (IMAB) has a market cap of $87.206 million USD. According to our data, I-Mab Biopharma is ranked No.7792 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $87.21 M |
25.88%
|
Dec 31, 2024 | $69.28 M |
-55.26%
|
Dec 29, 2023 | $0.15 B |
-54.55%
|
Dec 30, 2022 | $0.34 B |
-91.18%
|
Dec 31, 2021 | $3.86 B |
0.51%
|
Dec 31, 2020 | $3.84 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Akeso
9926.HK
|
$7.21 B |
0.444 B
|
China
|
Legend Biotech
LEGN
|
$6.87 B |
0.000 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Market Cap | = | IMAB Stock Price | * | IMAB Shares Outstanding |
= | $1.07 | * | 81.50 M | |
= | $87.21 M |